Effects of different corticosteroid doses and durations on smoke inhalation-induced acute lung injury and pulmonary fibrosis in the rat

International Immunopharmacology

Volumn 71, Issue , 2019, Pages 392-403

  Song, Li C ^a   Chen, Xu X ^a   Meng, Ji G ^a   Hu, Ming ^a   Huan, Jian B ^a   Wu, Jing ^a   Xiao, Kun ^a   Han, Zhi H ^a   Xie, Li X ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Acute lung injury; Coagulation; Glucocorticoid; Inflammation; Pulmonary fibrosis; Smoke inhalation

Indexed keywords

CHEMOKINE; COLLAGEN; FIBRIN; METHYLPREDNISOLONE; ANTIINFLAMMATORY AGENT; CYTOKINE;

ACUTE LUNG INJURY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; CYTOKINE PRODUCTION; DRUG DOSE COMPARISON; DRUG MEGADOSE; FIBRIN DEPOSITION; FIBRINOLYSIS; LOW DRUG DOSE; LUNG ALVEOLUS; LUNG FIBROSIS; MORTALITY RATE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; RAT; SMOKE; SURVIVAL RATE; ANIMAL; BLOOD CLOTTING; COMPLICATION; DISEASE MODEL; DOSE CALCULATION; DRUG EFFECT; HUMAN; IMMUNOLOGY; INFLAMMATION; LUNG; LUNG BURN; METABOLISM; PATHOLOGY; SPRAGUE DAWLEY RAT;

ACUTE LUNG INJURY; ANIMALS; ANTI-INFLAMMATORY AGENTS; BLOOD COAGULATION; CYTOKINES; DISEASE MODELS, ANIMAL; DRUG DOSAGE CALCULATIONS; HUMANS; INFLAMMATION; LUNG; METHYLPREDNISOLONE; NEUTROPHIL INFILTRATION; PULMONARY FIBROSIS; RATS; RATS, SPRAGUE-DAWLEY; SMOKE INHALATION INJURY;

EID: 85063677746     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2019.03.051     Document Type: Article

References (64)

1. Brusselaers, N., Monstrey, S., Vogelaers, D., Hoste, E., Blot, S., Severe burn injury in Europe: a systematic review of the incidence, etiology, morbidity, and mortality. Crit. Care, 14(5), 2010, R188, 10.1186/cc9300.
2. Monteiro, D., Silva, I., Egipto, P., Magalhaes, A., Filipe, R., Silva, A., Rodrigues, A., Costa, J., Inhalation injury in a burn unit: a retrospective review of prognostic factors. Ann. Burns Fire Disasters 30:2 (2017), 121–125.
3. Deutsch, C.J., Tan, A., Smailes, S., Dziewulski, P., The diagnosis and management of inhalation injury: an evidence based approach. Burns 44:5 (2018), 1040–1051, 10.1016/j.burns.2017.11.013.
4. Enkhbaatar, P., Pruitt, B.A. Jr., Suman, O., Mlcak, R., Wolf, S.E., Sakurai, H., Herndon, D.N., Pathophysiology, research challenges, and clinical management of smoke inhalation injury. Lancet 388:10052 (2016), 1437–1446, 10.1016/s0140-6736(16)31458-1.
5. Lange, M., Hamahata, A., Traber, D.L., Esechie, A., Jonkam, C., Bansal, K., Nakano, Y., Traber, L.D., Enkhbaatar, P., A murine model of sepsis following smoke inhalation injury. Biochem. Biophys. Res. Commun. 391:3 (2010), 1555–1560, 10.1016/j.bbrc.2009.12.124.
6. Albright, J.M., Davis, C.S., Bird, M.D., Ramirez, L., Kim, H., Burnham, E.L., Gamelli, R.L., Kovacs, E.J., The acute pulmonary inflammatory response to the graded severity of smoke inhalation injury. Crit. Care Med. 40:4 (2012), 1113–1121, 10.1097/CCM.0b013e3182374a67.
7. Kurzius-Spencer, M., Foster, K., Littau, S., Richey, K.J., Clark, B.M., Sherrill, D., Goodman, R.B., Boitano, S., Burgess, J.L., Tracheobronchial markers of lung injury in smoke inhalation victims. J. Burn Care Res. 29:2 (2008), 311–318, 10.1097/BCR.0b013e3181667991.
8. Kasper, M., Barth, K., Potential contribution of alveolar epithelial type I cells to pulmonary fibrosis. Biosci. Rep., 37(6), 2017, 10.1042/BSR20171301.
9. Hofstra, J.J., Vlaar, A.P., Knape, P., Mackie, D.P., Determann, R.M., Choi, G., van der Poll, T., Levi, M., Schultz, M.J., Pulmonary activation of coagulation and inhibition of fibrinolysis after burn injuries and inhalation trauma. J. Trauma 70:6 (2011), 1389–1397, 10.1097/TA.0b013e31820f85a7.
10. Backes, Y., van der Sluijs, K.F., Tuip de Boer, A.M., Hofstra, J.J., Vlaar, A.P., Determann, R.M., Knape, P., Mackie, D.P., Schultz, M.J., Soluble urokinase-type plasminogen activator receptor levels in patients with burn injuries and inhalation trauma requiring mechanical ventilation: an observational cohort study. Crit. Care, 15(6), 2011, R270, 10.1186/cc10550.
11. Zhu, F., Qiu, X., Wang, J., Jin, Y., Sun, Y., Lv, T., Xia, Z., A rat model of smoke inhalation injury. Inhal. Toxicol. 24:6 (2012), 356–364, 10.3109/08958378.2012.673179.
12. Thompson, B.T., Drazen, J.M., Chambers, R.C., Liu, K.D., Acute respiratory distress syndrome. N. Engl. J. Med. 377:6 (2017), 562–572, 10.1056/NEJMra1608077.
13. Ware, L.B., Matthay, M.A., Parsons, P.E., Thompson, B.T., Januzzi, J.L., Eisner, M.D., L. National Heart, N. Blood Institute Acute Respiratory Distress Syndrome Clinical Trials, Pathogenetic and prognostic significance of altered coagulation and fibrinolysis in acute lung injury/acute respiratory distress syndrome. Crit. Care Med. 35:8 (2007), 1821–1828, 10.1097/01.CCM.0000221922.08878.49.
14. Gouda, M.M., Shaikh, S.B., Bhandary, Y.P., Inflammatory and fibrinolytic system in acute respiratory distress syndrome. Lung 196:5 (2018), 609–616, 10.1007/s00408-018-0150-6.
15. Han, S., Mallampalli, R.K., The acute respiratory distress syndrome: from mechanism to translation. J. Immunol. 194:3 (2015), 855–860, 10.4049/jimmunol.1402513.
16. Thompson, B.T., Corticosteroids for ARDS. Minerva Anestesiol. 76:6 (2010), 441–447.
17. Hough, C.L., Steroids for acute respiratory distress syndrome?. Clin. Chest Med. 35:4 (2014), 781–795, 10.1016/j.ccm.2014.08.014.
18. Peter, J.V., John, P., Graham, P.L., Moran, J.L., George, I.A., Bersten, A., Corticosteroids in the prevention and treatment of acute respiratory distress syndrome (ARDS) in adults: meta-analysis. Bmj 336:7651 (2008), 1006–1009, 10.1136/bmj.39537.939039.BE.
19. Takaki, M., Ichikado, K., Kawamura, K., Gushima, Y., Suga, M., The negative effect of initial high-dose methylprednisolone and tapering regimen for acute respiratory distress syndrome: a retrospective propensity matched cohort study. Crit. Care, 21(1), 2017, 135, 10.1186/s13054-017-1723-0.
20. Khilnani, G.C., Hadda, V., Corticosteroids and ARDS: a review of treatment and prevention evidence. Lung India Off. Organ Indian Chest Soc. 28:2 (2011), 114–119, 10.4103/0970-2113.80324.
21. Tang, B.M., Craig, J.C., Eslick, G.D., Seppelt, I., McLean, A.S., Use of corticosteroids in acute lung injury and acute respiratory distress syndrome: a systematic review and meta-analysis. Crit. Care Med. 37:5 (2009), 1594–1603, 10.1097/CCM.0b013e31819fb507.
22. Marik, P.E., Meduri, G.U., Rocco, P.R., Annane, D., Glucocorticoid treatment in acute lung injury and acute respiratory distress syndrome. Crit. Care Clin. 27:3 (2011), 589–607, 10.1016/j.ccc.2011.05.007.
23. Meduri, G.U., Bridges, L., Shih, M.C., Marik, P.E., Siemieniuk, R.A.C., Kocak, M., Prolonged glucocorticoid treatment is associated with improved ARDS outcomes: analysis of individual patients' data from four randomized trials and trial-level meta-analysis of the updated literature. Intensive Care Med. 42:5 (2016), 829–840, 10.1007/s00134-015-4095-4.
24. Steinberg, K.P., Hudson, L.D., Goodman, R.B., Hough, C.L., Lanken, P.N., Hyzy, R., Thompson, B.T., Ancukiewicz, M., Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome. N. Engl. J. Med. 354:16 (2006), 1671–1684, 10.1056/NEJMoa051693.
25. Rocco, P.R., Souza, A.B., Faffe, D.S., Passaro, C.P., Santos, F.B., Negri, E.M., Lima, J.G., Contador, R.S., Capelozzi, V.L., Zin, W.A., Effect of corticosteroid on lung parenchyma remodeling at an early phase of acute lung injury. Am. J. Respir. Crit. Care Med. 168:6 (2003), 677–684, 10.1164/rccm.200302-256OC.
26. Rasooli, R., Pourgholamhosein, F., Kamali, Y., Nabipour, F., Mandegary, A., Combination therapy with pirfenidone plus prednisolone ameliorates Paraquat-induced pulmonary fibrosis. Inflammation 41:1 (2018), 134–142, 10.1007/s10753-017-0671-9.
27. Wuyts, W.A., Antoniou, K.M., Borensztajn, K., Costabel, U., Cottin, V., Crestani, B., Grutters, J.C., Maher, T.M., Poletti, V., Richeldi, L., Vancheri, C., Wells, A.U., Combination therapy: the future of management for idiopathic pulmonary fibrosis?. Lancet Respir. Med. 2:11 (2014), 933–942, 10.1016/s2213-2600(14)70232-2.
28. Raghu, G., Depaso, W.J., Cain, K., Hammar, S.P., Wetzel, C.E., Dreis, D.F., Hutchinson, J., Pardee, N.E., Winterbauer, R.H., Azathioprine combined with prednisone in the treatment of idiopathic pulmonary fibrosis: a prospective double-blind, randomized, placebo-controlled clinical trial. Am. Rev. Respir. Dis. 144:2 (1991), 291–296, 10.1164/ajrccm/144.2.291.
29. Kondoh, Y., Taniguchi, H., Yokoi, T., Nishiyama, O., Ohishi, T., Kato, T., Suzuki, K., Suzuki, R., Cyclophosphamide and low-dose prednisolone in idiopathic pulmonary fibrosis and fibrosing nonspecific interstitial pneumonia. Eur. Respir. J. 25:3 (2005), 528–533, 10.1183/09031936.05.00071004.
30. Glas, G.J., Muller, J., Binnekade, J.M., Cleffken, B., Colpaert, K., Dixon, B., Juffermans, N.P., Knape, P., Levi, M.M., Loef, B.G., Mackie, D.P., Malbrain, M., Schultz, M.J., Sluijs, K.F.v.d., HEPBURN - investigating the efficacy and safety of nebulized heparin versus placebo in burn patients with inhalation trauma. Trials, 15(1), 2014, 91, 10.1186/1745-6215-15-91.
31. Sheridan, R.L., Fire-related inhalation injury. N. Engl. J. Med. 375:5 (2016), 464–469, 10.1056/NEJMra1601128.
32. Demling, R.H., Smoke inhalation lung injury: an update. Eplasty, 8, 2008, e27.
33. Matthew, E., Warden, G., Dedman, J., A murine model of smoke inhalation. Am. J. Phys. Lung Cell. Mol. Phys. 280:4 (2001), L716–L723, 10.1152/ajplung.2001.280.4.L716.
34. Sun, L., Zhao, X., Li, D., Cai, Y., An, H., Wang, T., Cui, Z., Yang, H., Han, F., Ao, L., Liu, J., Cao, J., A dynamic smoke generation and nose-only inhalation exposure system for rats: preliminary results from studies of selected transportation materials. Inhal. Toxicol. 26:14 (2014), 897–907, 10.3109/08958378.2014.975874.
35. Matute-Bello, G., Downey, G., Moore, B.B., Groshong, S.D., Matthay, M.A., Slutsky, A.S., Kuebler, W.M., Acute Lung, G., Injury in animals study, An official American Thoracic Society workshop report: features and measurements of experimental acute lung injury in animals. Am. J. Respir. Cell Mol. Biol. 44:5 (2011), 725–738, 10.1165/rcmb.2009-0210ST.
36. Maknitikul, S., Luplertlop, N., Grau, G.E.R., Ampawong, S., Dysregulation of pulmonary endothelial protein C receptor and thrombomodulin in severe falciparum malaria-associated ARDS relevant to hemozoin. PLoS One, 12(7), 2017, e0181674, 10.1371/journal.pone.0181674.
37. Seam, N., Meduri, G.U., Wang, H., Nylen, E.S., Sun, J., Schultz, M.J., Tropea, M., Suffredini, A.F., Effects of methylprednisolone infusion on markers of inflammation, coagulation, and angiogenesis in early acute respiratory distress syndrome. Crit. Care Med. 40:2 (2012), 495–501, 10.1097/CCM.0b013e318232da5e.
38. Long, B., Koyfman, A., Controversies in corticosteroid use for sepsis. J. Emerg. Med. 53:5 (2017), 653–661, 10.1016/j.jemermed.2017.05.024.
39. Venkatesh, B., Finfer, S., Cohen, J., Rajbhandari, D., Arabi, Y., Bellomo, R., Billot, L., Correa, M., Glass, P., Harward, M., Joyce, C., Li, Q., McArthur, C., Perner, A., Rhodes, A., Thompson, K., Webb, S., Myburgh, J., A.T. Investigators, G. the Australian-New Zealand Intensive Care Society Clinical Trials, Adjunctive glucocorticoid therapy in patients with septic shock. N. Engl. J. Med. 378:9 (2018), 797–808, 10.1056/NEJMoa1705835.
40. Foncerrada, G., Culnan, D.M., Capek, K.D., Gonzalez-Trejo, S., Cambiaso-Daniel, J., Woodson, L.C., Herndon, D.N., Finnerty, C.C., Lee, J.O., Inhalation injury in the burned patient. Ann. Plast. Surg. 80:3 Suppl 2 (2018), S98–S105, 10.1097/sap.0000000000001377.
41. Cha, S.I., Kim, C.H., Lee, J.H., Park, J.Y., Jung, T.H., Choi, W.I., Han, S.B., Jeon, Y.J., Shin, K.C., Chung, J.H., Lee, K.H., Kim, Y.J., Lee, B.K., Isolated smoke inhalation injuries: acute respiratory dysfunction, clinical outcomes, and short-term evolution of pulmonary functions with the effects of steroids. Burns 33:2 (2007), 200–208, 10.1016/j.burns.2006.07.017.
42. Dries, D.J., Endorf, F.W., Inhalation injury: epidemiology, pathology, treatment strategies. Scand. J. Trauma Resuscitation Emerg. Med., 21, 2013, 31, 10.1186/1757-7241-21-31.
43. Reczynska, K., Tharkar, P., Kim, S.Y., Wang, Y., Pamula, E., Chan, H.K., Chrzanowski, W., Animal models of smoke inhalation injury and related acute and chronic lung diseases. Adv. Drug Deliv. Rev. 123 (2018), 107–134, 10.1016/j.addr.2017.10.005.
44. Midde, K.K., Batchinsky, A.I., Cancio, L.C., Shetty, S., Komissarov, A.A., Florova, G., Walker, K.P. 3rd, Koenig, K., Chroneos, Z.C., Allen, T., Chung, K., Dubick, M., Idell, S., Wood bark smoke induces lung and pleural plasminogen activator inhibitor 1 and stabilizes its mRNA in porcine lung cells. Shock 36:2 (2011), 128–137, 10.1097/SHK.0b013e31821d60a4.
45. White, M.J., Gomer, R.H., Trypsin, tryptase, and thrombin polarize macrophages towards a pro-fibrotic M2a phenotype. PLoS One, 10(9), 2015, e0138748, 10.1371/journal.pone.0138748.
46. Chimenti, L., Camprubi-Rimblas, M., Guillamat-Prats, R., Gomez, M.N., Tijero, J., Blanch, L., Artigas, A., Nebulized heparin attenuates pulmonary coagulopathy and inflammation through alveolar macrophages in a rat model of acute lung injury. Thromb. Haemost. 117:11 (2017), 2125–2134, 10.1160/TH17-05-0347.
47. Hoogerwerf, J.J., de Vos, A.F., Levi, M., Bresser, P., van der Zee, J.S., Draing, C., von Aulock, S., van der Poll, T., Activation of coagulation and inhibition of fibrinolysis in the human lung on bronchial instillation of lipoteichoic acid and lipopolysaccharide. Crit. Care Med. 37:2 (2009), 619–625, 10.1097/CCM.0b013e31819584f9.
48. Galon, J., Franchimont, D., Hiroi, N., Frey, G., Boettner, A., Ehrhart-Bornstein, M., O'Shea, J.J., Chrousos, G.P., Bornstein, S.R., Gene profiling reveals unknown enhancing and suppressive actions of glucocorticoids on immune cells. FASEB J. 16:1 (2002), 61–71, 10.1096/fj.01-0245com.
49. Cain, D.W., Cidlowski, J.A., Specificity and sensitivity of glucocorticoid signaling in health and disease. Best Pract. Res. Clin. Endocrinol. Metab. 29:4 (2015), 545–556, 10.1016/j.beem.2015.04.007.
50. Wang, X.Y., Chen, X.L., Wang, L., Chen, H.W., High-dose glucocorticoids increases the expression of mineralocorticoid receptor in vascular endothelial cells. Eur. Rev. Med. Pharmacol. Sci. 19:22 (2015), 4314–4323.
51. Liu, F., Pauluhn, J., Trubel, H., Wang, C., Single high-dose dexamethasone and sodium salicylate failed to attenuate phosgene-induced acute lung injury in rats. Toxicology 315 (2014), 17–23, 10.1016/j.tox.2013.11.005.
52. Shin, B., Kim, M., Yoo, H., Kim, S.J., Lee, J.E., Jeon, K., Tracheobronchial polyps following thermal inhalation injury. Tuberc. Respir. Dis. 76:5 (2014), 237–239, 10.4046/trd.2014.76.5.237.
53. Isshiki, T., Akiba, H., Nakayama, M., Harada, N., Okumura, K., Homma, S., Miyake, S., Cutting edge: anti-TIM-3 treatment exacerbates pulmonary inflammation and fibrosis in mice. J. Immunol. 199:11 (2017), 3733–3737, 10.4049/jimmunol.1700059.
54. Wigenstam, E., Elfsmark, L., Bucht, A., Jonasson, S., Inhaled sulfur dioxide causes pulmonary and systemic inflammation leading to fibrotic respiratory disease in a rat model of chemical-induced lung injury. Toxicology 368-369 (2016), 28–36, 10.1016/j.tox.2016.08.018.
55. Jonasson, S., Wigenstam, E., Koch, B., Bucht, A., Early treatment of chlorine-induced airway hyperresponsiveness and inflammation with corticosteroids. Toxicol. Appl. Pharmacol. 271:2 (2013), 168–174, 10.1016/j.taap.2013.04.037.
56. Leask, A., Abraham, D.J., TGF-beta signaling and the fibrotic response. FASEB J. 18:7 (2004), 816–827, 10.1096/fj.03-1273rev.
57. Mukherjee, S., Kolb, M.R., Duan, F., Janssen, L.J., Transforming growth factor-beta evokes Ca2+ waves and enhances gene expression in human pulmonary fibroblasts. Am. J. Respir. Cell Mol. Biol. 46:6 (2012), 757–764, 10.1165/rcmb.2011-0223OC.
58. Hosseinzadeh, A., Javad-Moosavi, S.A., Reiter, R.J., Yarahmadi, R., Ghaznavi, H., Mehrzadi, S., Oxidative/nitrosative stress, autophagy and apoptosis as therapeutic targets of melatonin in idiopathic pulmonary fibrosis. Expert Opin. Ther. Targets 22:12 (2018), 1049–1061, 10.1080/14728222.2018.1541318.
59. Crooks, M.G., Hart, S.P., Coagulation and anticoagulation in idiopathic pulmonary fibrosis. Eur. Respir. Rev. 24:137 (2015), 392–399, 10.1183/16000617.00008414.
60. Schuliga, M., Grainge, C., Westall, G., Knight, D., The fibrogenic actions of the coagulant and plasminogen activation systems in pulmonary fibrosis. Int. J. Biochem. Cell Biol. 97 (2018), 108–117, 10.1016/j.biocel.2018.02.016.
61. Ruan, S.Y., Lin, H.H., Huang, C.T., Kuo, P.H., Wu, H.D., Yu, C.J., Exploring the heterogeneity of effects of corticosteroids on acute respiratory distress syndrome: a systematic review and meta-analysis. Crit. Care, 18(2), 2014, R63, 10.1186/cc13819.
62. Windle, R.J., Wood, S.A., Kershaw, Y.M., Lightman, S.L., Ingram, C.D., 外援MP可以抑制HPAAdaptive changes in basal and stress-induced HPA activity in lactating and post-lactating female rats. Endocrinology 154:2 (2013), 749–761, 10.1210/en.2012-1779.
63. Abdul, A.J., Ghai, B., Bansal, D., Sachdeva, N., Bhansali, A., Dhatt, S.S., Hypothalamic pituitary adrenocortical axis suppression following a single epidural injection of methylprednisolone acetate. Pain Physician 20:7 (2017), E991–E1001.
64. Andrews, M.H., Wood, S.A., Windle, R.J., Lightman, S.L., Ingram, C.D., Acute glucocorticoid administration rapidly suppresses basal and stress-induced hypothalamo-pituitary-adrenal axis activity. Endocrinology 153:1 (2012), 200–211, 10.1210/en.2011-1434.